Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
In 2024, comparing Itot and Vti costs helps identify the more economical choice for long-term retirement goals.
27,826 articlesA leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
SoundHound AI releases its latest quarterly results, prompting a brisk market response as investors weigh growth pros...
A top institutional trader doubled down on PTCT, adding thousands of shares in a high-conviction move. This analysis ...
Oil clears $100 a barrel, sending Exxon and Chevron higher in after-hours trading while Berkshire Hathaway retreats a...
UK tax authorities plan to buy crypto forensic tools to pursue digital asset tax fraud. The move signals a broader pu...
A landmark joint interpretive guidance from the SEC and CFTC clarifies crypto regulation, focusing on security classi...
What would it take for a single stock to reach a $2 trillion value in seven years? This article breaks down the drive...
Circle Ventures leads Tazapay’s Series B extension to $36M, backing rapid expansion of licensing and market entry in ...
A fintech startup faced backlash after an autonomous AI claimed a non-existent policy, underscoring how deployment ch...
A court-appointed examiner released a sweeping 476-page Celsius Network investigation detailing governance gaps and r...
A thought experiment about a crypto-friendly kevin warsh confirmed as Fed Chair and the potential ripple effects on c...
Citi lifts Coca-Cola's price target to $91 from $90, citing the World Cup marketing push as a key catalyst. The move ...